Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Outsourcing in Clinical Trials New England 2022

Outsourcing in Clinical Trials New England 2022

October 12-13, 2022 | Boston, MA

We are excited to share that we will be attending and exhibiting at Outsourcing in Clinical Trials New England in Boston on October 12th-13th. The agenda for this year’s event will focus on promoting successful collaboration between parties in the clinical trials community and providing attendees with practical take-aways they can apply to their own studies.

The event will consist of 4 tracks:

  • Clinical Operations & Outsourcing
  • Decentralized & Hybrid Trials
  • Rare Disease Trials
  • Technology, Innovation & Devices

Join us in Boston for a networking focused event with industry leading presentations, interactive sessions, and the most innovative solution providers in attendance.

Events
Category:
Clinical Operations Clinical Trials Healthcare Technology Hybrid Clinical Trials Rare Disease
Published on:
September 20, 2022
Our delegates
Bridget Bojic

Bridget Bojic

 Associate Manager, Clinical Development, Alira Health

Brendan Wrigley

 Manager, Clinical Development, Alira Health

Would you like to meet Alira Health at OCT New England in Boston? Contact us to set up a meeting.

Additional Clinical Trial Resources:

Diversity in Clinical Trials: A Blog Series
How to Integrate the Patient Voice in Rare Disease Clinical Trials

Contact us

Related news

Articles August 24, 2026
FDA Initiatives and Programs to Support Development of Treatments for Rare Diseases in 2026
Discover FDA programs in 2026 that foster rare disease drug development, offering guidance, funding, and regulatory support for innovators.
Drug Development Rare Disease
Articles July 21, 2026
Preparing Rare Disease Manufacturers for JCA: The Role of Early Stakeholder Engagement
Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.
Healthcare Technology Rare Disease Regulatory
Articles June 4, 2026
Patient Involvement Under EU HTA: What JSC and JCA Mean for Pharma, Biotech, and Medtech Companies
Learn where patient involvement fits within JSC and JCA under EU HTA Regulation and how to prepare your engagement strategy.
EU Healthcare Technology Regulatory
Articles May 29, 2026
Rare Disease Trial Recruitment: The Role of Patient Registries
Explore how registries in rare disease trial recruitment connect sponsors with patient communities to improve identification and enrollment.
Interview Rare Disease
Articles May 27, 2026
Data Management in Complex Clinical Trials: The Strategic Role of the FSP Model
Explore how data management FSP strengthens governance, visibility, and efficiency across multi-vendor trials for more confident execution.
Clinical Trials
Articles May 21, 2026
Clinical Trial Excellence in 2026: Managing the Complexity of Modern Clinical Development
Learn what clinical trial excellence means in complex product development and how biotech leaders can manage new complexity, risk, and executional pressure.
Clinical Operations Interview
Webinars May 20, 2026
Cross-Border Access to Rare Disease Clinical Trials: A Patient-Centric Approach to Feasibility and Execution
Watch the webinar to get practical insights on cross-border rare disease clinical trials and explore patient-centric strategies that support sponsor execution and patient access.
Patient Engagement Rare Disease
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.